VSee Health, Inc. (VSEE) - Net Assets
Based on the latest financial reports, VSee Health, Inc. (VSEE) has net assets worth $-5.58 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($18.71 Million) and total liabilities ($24.28 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read VSee Health, Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.58 Million |
| % of Total Assets | -29.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | -100.02% |
| 10-Year Change | N/A |
| Growth Volatility | 9226.39 |
VSee Health, Inc. - Net Assets Trend (2020–2025)
This chart illustrates how VSee Health, Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore VSEE total assets for the complete picture of this company's asset base.
Annual Net Assets for VSee Health, Inc. (2020–2025)
The table below shows the annual net assets of VSee Health, Inc. from 2020 to 2025. For live valuation and market cap data, see VSee Health, Inc. (VSEE) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-18.49K | 0.00% |
| 2024-12-31 | $-18.49K | +99.57% |
| 2023-12-31 | $-4.30 Million | -211386.47% |
| 2022-12-31 | $-2.03K | -100.00% |
| 2021-12-31 | $113.39 Million | +18352.79% |
| 2020-12-31 | $614.49K | -- |
Equity Component Analysis
This analysis shows how different components contribute to VSee Health, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6232174600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.63K | % |
| Other Components | $67.68 Million | % |
| Total Equity | $-18.49K | 100.00% |
VSee Health, Inc. Competitors by Market Cap
The table below lists competitors of VSee Health, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Imperial Pacific Ltd
AU:IPC
|
$7.69 Million |
|
Fatfish Group Ltd
AU:FFG
|
$7.69 Million |
|
Infimer Ltd
TA:INFR
|
$7.70 Million |
|
Stenocare AS
CO:STENO
|
$7.70 Million |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
$7.68 Million |
|
Mountain Province Diamonds Inc
TO:MPVD
|
$7.68 Million |
|
Filtronic
LSE:FTC
|
$7.68 Million |
|
NINE MILE METALS LTD
F:KQ9
|
$7.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in VSee Health, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -18,488 to -18,488, a change of 0.
- Net loss of 57,702,015 reduced equity.
- Other factors increased equity by 57,702,015.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-57.70 Million | -312105.23% |
| Other Changes | $57.70 Million | +312105.23% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares VSee Health, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.06 | $0.19 | x |
| 2021-12-31 | $11.40 | $0.19 | x |
| 2022-12-31 | $0.04 | $0.19 | x |
| 2023-12-31 | $-0.40 | $0.19 | x |
| 2024-12-31 | $0.00 | $0.19 | x |
| 2025-12-31 | $0.00 | $0.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently VSee Health, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -553.69%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-31.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 42.13% | 3.80% | 2.50x | 4.44x | $197.43K |
| 2021 | 0.42% | 6.49% | 0.06x | 1.04x | $-10.86 Million |
| 2022 | -231.81% | -13.11% | 2.44x | 7.24x | $-872.28K |
| 2023 | 0.00% | -65.26% | 7.16x | 0.00x | $-3.37 Million |
| 2024 | 0.00% | -553.69% | 0.52x | 0.00x | $-57.70 Million |
| 2025 | 0.00% | -553.69% | 0.52x | 0.00x | $-57.70 Million |
Industry Comparison
This section compares VSee Health, Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $363,436,353
- Average return on equity (ROE) among peers: -160.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| VSee Health, Inc. (VSEE) | $-5.58 Million | 42.13% | N/A | $7.68 Million |
| Aclarion Inc (ACON) | $2.23 Million | -317.55% | 0.31x | $1.99 Million |
| American Well Corp (AMWL) | $480.19 Million | -140.60% | 0.23x | $90.87 Million |
| Heartbeam Inc (BEAT) | $-26.87 Million | 0.00% | 0.00x | $30.38 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-3.06 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $612.55 Million | -25.24% | 8.03x | $8.82 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-70.63 Million | 0.00% | 0.00x | $253.42 Million |
| CareCloud Inc. (CCLD) | $101.25 Million | -8.70% | 0.36x | $117.28 Million |
| Certara Inc (CERT) | $492.05 Million | -1.81% | 1.11x | $983.48 Million |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $1.99 Billion | 0.49% | 3.21x | $277.75 Million |
About VSee Health, Inc.
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient en… Read more